Baird Medical Investment Holdings stock analysis
Want to see BDMD full AI Analyst Report?
Baird Medical Investment Holdings (BDMD) Stock Price & Analysis
BDMD Stock Chart & Stats
- Day’s Range
- $0.09 - $0.10
- 52-Week Range
- $0.07 - $3.70
- Previous Close
- $0.10
- Volume
- N/A
- Average Volume (3M)
- 33.80M
- Market Cap
- $5.82M
- Enterprise Value
- $54.13M
- Total Cash (Recent Filing)
- $289.08K
- Total Debt (Recent Filing)
- $14.22M
- Price to Earnings (P/E)
- ―
- Beta
- -0.33
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
H1 2026 Revenue And Profit Recovery
The H1 2026 rebound shows that international sales, licensing revenue, and lower operating expenses can materially improve results after the 2025 downturn. If sustained, this combination provides a stronger base for restoring profitability and funding expansion in subsequent reporting periods.
Medtech Portfolio And International Expansion
A portfolio spanning microwave ablation, IRE products, and robotic ablation gives BDMD multiple technology avenues within minimally invasive tumor treatment. Its expanding commercial presence outside China, including the U.S., supports broader market access and reduces reliance on one geography or product.
Manageable Reported Leverage
Reported debt remains below equity, which provides some balance-sheet support despite the recent loss and decline in equity. This cushion can help the company continue operating and pursue its strategy, although preserving it depends on improving profitability and cash generation.
Bears Say
Sharp 2025 Profitability Deterioration
The 2025 reversal indicates that prior profitability was not yet consistently durable, with revenue contraction accompanied by deeply negative operating and net margins. Continued earnings volatility could weaken reinvestment capacity, pressure equity, and make future performance more dependent on a successful operating recovery.
Persistent Negative Cash Generation
Repeatedly negative operating and free cash flow means the business has not been funding its needs internally across the periods shown. If this continues, BDMD may need additional external capital to sustain operations and expansion, increasing financial dependence and reducing flexibility in capital allocation.
Nasdaq Minimum-Bid Compliance Risk
The Nasdaq deficiency creates an ongoing listing-compliance requirement that can distract management and impose pressure to execute a share consolidation or other corrective action. Failure to regain compliance within the available periods could reduce trading access and complicate future financing.
Baird Medical Investment Holdings News
Baird Medical signs China distribution deal with China Resources unit
Baird Medical (BDMD) announced that its subsidiary in the People’s Republic of China, Nanjing Changcheng Medical Equipment Company Limited, has entered into a distribution agreement with China Resources Pharmaceutical Commercial
Baird Medical gets Vietnam registrations for microwave ablation products
Baird Medical (BDMD) Investment Holdings announced additional medical device registrations in Vietnam. Baird Medical received Class C medical device registration certificates for several products within its microwave ablation portfolio, including
Baird Medical microwave ablation system, needle receive Pakistan registrations
Baird Medical (BDMD) announced that the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from the Drug Regulatory Authority of Pakistan, further supporting the
Baird Medical, Tianjin Yuanshan Medical enter cooperation agreement
Baird Medical (BDMD) and Tianjin Yuanshan Medical announced the signing of a strategic cooperation agreement to establish a long-term partnership focused on global development and commercialization of next-generation IRE technologies.
BDMD FAQ
What was Baird Medical Investment Holdings’s price range in the past 12 months?
What is Baird Medical Investment Holdings’s market cap?
When is Baird Medical Investment Holdings’s upcoming earnings report date?
How were Baird Medical Investment Holdings’s earnings last quarter?
Is Baird Medical Investment Holdings overvalued?
Does Baird Medical Investment Holdings pay dividends?
What is Baird Medical Investment Holdings’s EPS estimate?
How many shares outstanding does Baird Medical Investment Holdings have?
What happened to Baird Medical Investment Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Baird Medical Investment Holdings?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Baird Medical Investment Holdings
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Haimei Wu
- Employees
- 146
- Website
- www.bairdmed.com
- Address
- Baide Building, Building 11, Guangzhou, GD, 510000, CN
Baird Medical Investment Holdings (BDMD) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 3 | 15 |
| Technical Analysis | 4 | 3 | 3 |
| Moving Averages | 0 | 0 | 12 |











